Covid-۱۹ in Children with Emphasis on Prevention: A Rapid Review

Publish Year: 1401
نوع سند: مقاله ژورنالی
زبان: Persian
View: 126

This Paper With 8 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_HEPR-1-1_002

تاریخ نمایه سازی: 20 اردیبهشت 1401

Abstract:

Children of all ages can be infected with coronavirus disease (COVID-۱۹), and experience complications. Children with COVID-۱۹ might present with many symptoms, a few symptoms, or be asymptomatic. The most common symptoms in children are fever and dry cough, and other common symptoms include nasal congestion or a runny nose, fatigue, and headache. Evidence suggests that many children develop long-term COVID-۱۹. As of September ۲۲, ۲۰۲۰, no vaccine trials were conducted on children under ۱۸ years. According to the CDC, adolescents aged ۱۶ or ۱۷ are eligible for the Pfizer COVID-۱۹ vaccine, but not Moderna or Janssen (Johnson & Johnson) vaccines. As of March ۲۰۲۱, Moderna and Pfizer/Biotech had begun vaccine trials on children, and Johnson & Johnson planned to do the same. Children and adolescents are generally at a lower risk of infection, and if an infection occurs, it is likely to be mild. However, some children and young people have had severe experiences with the disease, and a few have died. COVID-۱۹-related measures have a profound effect on health and well-being, and for some, the impact will be lifelong.

Authors

Amir Hosein Ghazizadeh Hashemi

Assistant Professor of Otorhinolaryngology, Shaheed Beheshti University of Medical Sciences, Tehran, Iran.

Amer Yazdanparast

Assistant Professor of Pediatric Cardiology, Department of Pediatrics, Faculty of Medicine, Bushehr University of Medical Sciences, Bushehr, Iran.

Masumeh Saeidi

Department of Medical Education, Faculty of Medicine, Tehran University of Medical Sciences, Tehran, Iran.